It has been estimated that 347 million people suffer from diabetes worldwide [ 34 ], and prevalence exhibits an increasing trend [ 35 ].
← all excerpts
Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece.
1
—
—